These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30909217)

  • 1. Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.
    Aiello Bowles EJ; Crane PK; Walker RL; Chubak J; LaCroix AZ; Anderson ML; Rosenberg D; Keene CD; Larson EB
    J Alzheimers Dis; 2019; 68(3):1071-1083. PubMed ID: 30909217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
    Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
    Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition.
    Negash S; Wilson RS; Leurgans SE; Wolk DA; Schneider JA; Buchman AS; Bennett DA; Arnold SE
    Curr Alzheimer Res; 2013 Oct; 10(8):844-51. PubMed ID: 23919768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
    Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
    Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of deep learning to understand resilience to Alzheimer's disease pathology.
    Lee CS; Latimer CS; Henriksen JC; Blazes M; Larson EB; Crane PK; Keene CD; Lee AY
    Brain Pathol; 2021 Nov; 31(6):e12974. PubMed ID: 34009663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concept of resilience to Alzheimer's Disease: current definitions and cellular and molecular mechanisms.
    de Vries LE; Huitinga I; Kessels HW; Swaab DF; Verhaagen J
    Mol Neurodegener; 2024 Apr; 19(1):33. PubMed ID: 38589893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology.
    Negash S; Xie S; Davatzikos C; Clark CM; Trojanowski JQ; Shaw LM; Wolk DA; Arnold SE
    Alzheimers Dement; 2013 May; 9(3):e89-95. PubMed ID: 23127468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study.
    Robinson JL; Corrada MM; Kovacs GG; Dominique M; Caswell C; Xie SX; Lee VM; Kawas CH; Trojanowski JQ
    Acta Neuropathol; 2018 Sep; 136(3):377-388. PubMed ID: 29916037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Eissman JM; Dumitrescu L; Mahoney ER; Smith AN; Mukherjee S; Lee ML; Scollard P; Choi SE; Bush WS; Engelman CD; Lu Q; Fardo DW; Trittschuh EH; Mez J; Kaczorowski CC; Hernandez Saucedo H; Widaman KF; Buckley RF; Properzi MJ; Mormino EC; Yang HS; Harrison TM; Hedden T; Nho K; Andrews SJ; Tommet D; Hadad N; Sanders RE; Ruderfer DM; Gifford KA; Zhong X; Raghavan NS; Vardarajan BN; ; ; ; Pericak-Vance MA; Farrer LA; Wang LS; Cruchaga C; Schellenberg GD; Cox NJ; Haines JL; Keene CD; Saykin AJ; Larson EB; Sperling RA; Mayeux R; Cuccaro ML; Bennett DA; Schneider JA; Crane PK; Jefferson AL; Hohman TJ
    Brain; 2022 Jul; 145(7):2541-2554. PubMed ID: 35552371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer's disease.
    Morgan GR; Carlyle BC
    Sci Rep; 2024 Mar; 14(1):7161. PubMed ID: 38531951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics.
    Carlyle BC; Kandigian SE; Kreuzer J; Das S; Trombetta BA; Kuo Y; Bennett DA; Schneider JA; Petyuk VA; Kitchen RR; Morris R; Nairn AC; Hyman BT; Haas W; Arnold SE
    Neurobiol Aging; 2021 Sep; 105():99-114. PubMed ID: 34052751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project.
    Wallace LMK; Theou O; Godin J; Andrew MK; Bennett DA; Rockwood K
    Lancet Neurol; 2019 Feb; 18(2):177-184. PubMed ID: 30663607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive resilience and severe Alzheimer's disease neuropathology.
    Ahangari N; Fischer CE; Schweizer TA; Munoz DG
    Aging Brain; 2023; 3():100065. PubMed ID: 36911256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response.
    de Vries LE; Jongejan A; Monteiro Fortes J; Balesar R; Rozemuller AJM; Moerland PD; Huitinga I; Swaab DF; Verhaagen J
    Acta Neuropathol Commun; 2024 Apr; 12(1):68. PubMed ID: 38664739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology.
    Yu L; Wilson RS; Schneider JA; Bennett DA; Boyle PA
    J Alzheimers Dis; 2017; 56(4):1485-1493. PubMed ID: 28157101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.
    Driscoll I; Resnick SM; Troncoso JC; An Y; O'Brien R; Zonderman AB
    Ann Neurol; 2006 Dec; 60(6):688-95. PubMed ID: 17192929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
    Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
    JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer's disease: a case-control study.
    Buciuc M; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Boeve BF; Knopman DS; Parisi JE; Petersen RC; Dickson DW; Josephs KA
    Neurobiol Aging; 2020 Aug; 92():92-97. PubMed ID: 32408057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
    Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
    Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.